AMGEN INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Amgen Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2010 to Q4 2023.
  • Amgen Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $957M, a 33.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $957M +$239M +33.3% Dec 31, 2023 10-K 2024-02-14
Q4 2022 $718M +$55M +8.3% Dec 31, 2022 10-K 2024-02-14
Q4 2021 $663M +$92M +16.1% Dec 31, 2021 10-K 2023-02-09
Q4 2020 $571M +$54M +10.4% Dec 31, 2020 10-K 2022-02-16
Q4 2019 $517M +$8M +1.57% Dec 31, 2019 10-K 2021-02-09
Q4 2018 $509M +$12M +2.41% Dec 31, 2018 10-K 2020-02-12
Q4 2017 $497M +$116M +30.4% Dec 31, 2017 10-K 2019-02-13
Q4 2016 $381M +$54M +16.5% Dec 31, 2016 10-K 2018-02-13
Q4 2015 $327M -$9M -2.68% Dec 31, 2015 10-K 2017-02-14
Q4 2014 $336M +$22M +7.01% Dec 31, 2014 8-K 2016-10-31
Q4 2013 $314M +$41M +15% Dec 31, 2013 10-K 2015-02-19
Q4 2012 $273M +$147M +117% Dec 31, 2012 10-K 2014-02-24
Q4 2011 $126M +$46M +57.5% Dec 31, 2011 10-K 2013-02-27
Q4 2010 $80M Dec 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.